Pressure Biosciences (PBIO) Stock Statistics & Valuation Metrics

Pressure Biosciences has a market cap or net worth of $172.06K. The enterprise value is $29.39M.

Pressure Biosciences has 40,967,083 shares outstanding. The number of shares has decreased by -2.65% in one year.

Pressure Biosciences’s return on equity (ROE) is 0.89 and return on invested capital (ROIC) is 96.35%.

The current PE Ratio of Pressure Biosciences is -0.26. Pressure Biosciences’s PEG ratio is >-0.01.

In the last 12 months, Pressure Biosciences had revenue of 1.98M and earned -29.31M in profits. Earnings per share was -1.51.

In the last 12 months, operating cash flow was -4.43M and capital expenditures -7.49M, giving a free cash flow of -11.92M billion.

Pressure Biosciences pays an annual dividend of ―, resulting in a dividend yield of ―

Pressure Biosciences upcoming earnings date is May 15, 2025, TBA Not Confirmed.

Pressure Biosciences as a current ratio of 0.02, with Debt / Equity ratio of -78.42%

In the past 12 months, Pressure Biosciences has paid 0.00 in taxes.

Pressure Biosciences EV to EBITDA ratio is -3.25, with an EV/FCF ratio of -9.55.

Pressure Biosciences has $14.25K in cash and marketable securities with $29.19M in debt, giving a net cash position of $29.18M billion.

Gross margin is 38941.00%, with operating margin of -480.51%, and net profit margin of -1482.19%.

The average price target for Pressure Biosciences is ―, which is 11.43% higher than the current price. The consensus rating is ―